Technology

STAT+: Lilly’s Jaypirca approved as first-line CLL therapy

2026-10-05 13:55
474 views
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy

Scott Olson/Getty Images By Meghana KeshavanOct. 5, 2026 Biotech Correspondent Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay ...

Scott Olson/Getty Images

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

I’m hanging out with my 8-year-old pal, Silas Mirza-Ladd, who wants to be featured in a newspaper one day. So, Silas, you’re the inspiration for today’s Readout — along with stem cell hijinx and drug pricing woes.

“Meow,” Mirza-Ladd says.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
Source: Meghana Keshavan · www.statnews.com